Key facts
- This page summarizes David M. Stack's Form 4 filing for Pacira BioSciences, Inc. (PCRX).
- 10 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 13 May 2021, 18:01.
David M. Stack - 24 Mar 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)
- Reporting relationship
- CEO and Chairman, Director
- Issuer ticker
- PCRX
- Reported as of
- 24 Mar 2021
- Net transaction value
- -$2,151,873
- SEC form
- 4
- Accepted by SEC
- 13 May 2021, 18:01:59 UTC
- Next SEC filing
- 07 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kristen Williams, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David M. Stack filed Form 4 for Pacira BioSciences, Inc. (PCRX) on 13 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$2,151,873.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PCRX
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -1,080
- Change %
- -1.1%
- Price
- $0.000000
- Shares after
- 97,273
- Date
- 24 Mar 2021
- Ownership
- By Three Colleens Investment, LLC
- Footnotes
- F1
PCRX
transaction
Common Stock
Options Exercise
- Transaction value
- $229,712
- Shares
- +21,250
- Change %
- +28%
- Price
- $10.81
- Shares after
- 97,311
- Date
- 11 May 2021
- Ownership
- Direct
- Footnotes
- F2
PCRX
transaction
Common Stock
Sale
- Transaction value
- $809,468
- Shares
- -13,318
- Change %
- -14%
- Price
- $60.78
- Shares after
- 83,993
- Date
- 11 May 2021
- Ownership
- Direct
- Footnotes
- F2, F3
PCRX
transaction
Common Stock
Sale
- Transaction value
- $485,359
- Shares
- -7,932
- Change %
- -9.4%
- Price
- $61.19
- Shares after
- 76,061
- Date
- 11 May 2021
- Ownership
- Direct
- Footnotes
- F2, F4
PCRX
transaction
Common Stock
Options Exercise
- Transaction value
- $229,712
- Shares
- +21,250
- Change %
- +28%
- Price
- $10.81
- Shares after
- 97,311
- Date
- 12 May 2021
- Ownership
- Direct
- Footnotes
- F2
PCRX
transaction
Common Stock
Sale
- Transaction value
- $180,457
- Shares
- -2,970
- Change %
- -3.1%
- Price
- $60.76
- Shares after
- 94,341
- Date
- 12 May 2021
- Ownership
- Direct
- Footnotes
- F2, F5
PCRX
transaction
Common Stock
Sale
- Transaction value
- $910,652
- Shares
- -14,669
- Change %
- -16%
- Price
- $62.08
- Shares after
- 79,672
- Date
- 12 May 2021
- Ownership
- Direct
- Footnotes
- F2, F6
PCRX
transaction
Common Stock
Sale
- Transaction value
- $225,363
- Shares
- -3,611
- Change %
- -4.5%
- Price
- $62.41
- Shares after
- 76,061
- Date
- 12 May 2021
- Ownership
- Direct
- Footnotes
- F2, F7
PCRX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,596
- Date
- 24 Mar 2021
- Ownership
- By Stack Schroon Mohawk FLP
- Footnotes
- F1
PCRX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 315
- Date
- 24 Mar 2021
- Ownership
- By LCK Investment LLC
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PCRX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -21,250
- Change %
- -16%
- Price
- $0.000000
- Shares after
- 109,920
- Date
- 11 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,250
- Exercise price
- $10.81
- Footnotes
- F8
PCRX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -21,250
- Change %
- -19%
- Price
- $0.000000
- Shares after
- 88,670
- Date
- 12 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,250
- Exercise price
- $10.81
- Footnotes
- F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
Footnote F2
The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.995, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 7.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.68, inclusive.
Footnote F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.33 to $61.31, inclusive.
Footnote F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.355 to $62.35, inclusive.
Footnote F7
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.355 to $62.595, inclusive.
Footnote F8
The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.